PHT-1
PT
Menu
Search

Sections

  • Home
  • News
  • Analysis
    • Features
    • Comment
    • Data Insights
    • Projects
  • Sectors
    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area
      • Cardiovascular
      • Central Nervous System
      • Immunology
      • Infectious Disease
      • Oncology
      • Respiratory
  • Themes
    • Artificial Intelligence
    • Corporate Governance
    • Cloud
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19
  • Insights
    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media
  • Companies
    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content
  • Pricing and Market Access
  • Events
  • Reports
  • Awards & Rankings
  • Magazine

GlobalData

  • About us
  • Advertise With Us
  • Contact Us
  • Our Marketing Solutions
  • GlobalData Reports
  • Visit GlobalData

From Our Partners

  • Precision medicine and digital health innovation for disease diagnosis, care and treatment
  • Enabling process intensification in biopharma manufacturing
  • Specialty drug launch strategy and operations
  • The next chapter of clinical trial services
  • Future Pharma Services
  • Putting quality first in the pharma supply chain
  • Enabling better biopharmaceutical manufacturing
  • Pharmaceutical Grade Silicone Manufacturer
  • Maximising molecule potential
  • News
  • Analysis

    Sections

    • Features
    • Comment
    • Data Insights
    • Projects

    Latest

    • RFID: The future of smart labelling?
    • ‘Right shoring’ API production in Europe
    • Risk of venous thromboembolism in Covid-19 outpatients found to be low
  • Sectors

    Sections

    • Clinical Trials
    • Drug Manufacturers
    • Therapy Area

    Latest

    • ‘Right shoring’ API production in Europe
    • Sanofi’s Dupixent receives EC approval for atopic dermatitis
    • InvisiShield and Gladstone partner to develop intranasal preventatives
  • Themes

    Sections

    • Artificial Intelligence
    • Cloud
    • Corporate Governance
    • Cybersecurity
    • Environmental Sustainability
    • Internet of Things
    • Robotics
    • Social Responsibility
    • Covid-19

    Latest

    • Risk of venous thromboembolism in Covid-19 outpatients found to be low
    • InvisiShield and Gladstone partner to develop intranasal preventatives
    • Bioassay
  • Insights

    Sections

    • Deals
    • Jobs
    • Filings
    • Patents
    • Social Media

    Latest

    • Merck reports rise in group net sales in fiscal 2022
    • AbbVie reports rise in full-year 2022 net revenues
    • Teva Pharmaceutical reports 5% fall in Q4 2022 revenue
  • Companies

    Sections

    • Company A-Z
    • Company Categories
    • Products & Services
    • Company Releases
    • White Papers
    • Videos
    • Buyer’s Guides
    • Partner Content

    Latest

    • Optimising biopharma production through process intensification
    • Quality first: How pharma can meet injectables demand while staying compliant
    • Cannabidiol milling: Selecting the right equipment for CBD testing
  • Events
  • Reports
PT
October 30, 2015

Effectively Addressing and Remediating FDA’s Form 483 Findings, Warning Letters

IndiaProduction

Share this article

IndiaProduction

Recommended Reports

Complement Factor D (C3 Convertase Activator or Adipsin or P...

Atrial Natriuretic Peptide Receptor 1 (Atrial Natriuretic Pe...

Squalene Monooxygenase (Squalene Epoxidase or SQLE or EC 1.1...

Clostridium difficile Toxin A (toxA or EC 3.4.22.) Drugs in ...

Dihydrofolate Reductase (DHFR or EC 1.5.1.3) Drugs in Develo...

View All

Companies Intelligence

View All
PharmaceuticalTechnology

The leading site for news and procurement in the pharmaceutical industry

  • About us
  • Advertise with us
  • Contact us
  • Editorial approach
  • Newsletters
  • Our marketing solutions
  • Privacy policy
  • Terms and conditions

Powered by Pharma Tech Logo

© Verdict Media Limited 2023

  • Lost Password Back ⟶
  • Login
  • Register
Lost Password?
Registration is disabled.